missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LRRK2 (WT) Recombinant Protein
Recombinant Protein
$952.00 - $24070.00
Specifications
Accession Number | Q5S007 |
---|---|
Concentration | See Label |
For Use With (Application) | Kinase Assay |
Formulation | proprietary buffer with no preservative |
Gene ID (Entrez) | 120892 |
Catalog Number | Mfr. No. | Quantity | Price | Quantity | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity | ||||||
A15198
![]() |
Invitrogen™
A15198 |
100 ÎĽg |
Each for $5,460.00
|
|
||||||
A15197
![]() |
Invitrogen™
A15197 |
10 ÎĽg |
Each for $952.00
|
|
||||||
A15199
![]() |
Invitrogen™
A15199 |
1 mg |
N/A
|
N/A | ||||||
Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance. | ||||||||||
Description
LRRK2 (Leucine Rich Repeat Kinase 2) is a Protein Coding gene. Diseases associated with LRRK2 include Parkinson Disease 8, Autosomal Dominant and Hereditary Late-Onset Parkinson Disease. Among its related pathways are Signaling by PTK6 and ncRNAs involved in Wnt signaling in hepatocellular carcinoma. Gene Ontology (GO) annotations related to LRRK2 (G2019S Mutant) include protein homodimerization activity and transferase activity, transferring phosphorus-containing groups. An important paralog of LRRK2 (G2019S Mutant) is TNNI3K. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene, which codes for a multidomain protein kinase, are considered the most common genetic cause of late-onset autosomal-dominant Parkinson's disease.Specifications
Q5S007 | |
Kinase Assay | |
120892 | |
LRRK2 (WT) | |
LRRK2 (WT) | |
Unconjugated | |
Recombinant | |
Full length | |
Baculovirus | |
Recombinant, Full Length | |
Neurobiology |
See Label | |
proprietary buffer with no preservative | |
288 kDa | |
LRRK2 | |
LRRK Kinase Family | |
Human | |
DYKDDDDK-tag | |
-80°C, Avoid Freeze/Thaw Cycles | |
Kinases & Inhibitors | |
Liquid |